French Registry Study Shows One-Month CAR-T Response Doesn’t Predict Final Outcome

Consortium: LYSA / LYSARC · Registry: DESCAR-T · Population: 1,542 Adults with Large B-Cell Lymphoma · Publication: Bone Marrow Transplantation · Date: August 21, 2026 Summary A French nationwide registry analysis of 1,542 adults with large B-cell lymphoma clarifies how response evolves after CD19 CAR-T…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Terremoto – $108M Series C Degrader Platform
Nurix–Roche BTK Degrader Deal Closes
Silence Therapeutics Prices Upsized $175 Million Offering After Positive Divesiran Data
Lilly + Ascidian – $1.9B RNA Exon Editing Deal